Irritable Bowel Syndrome: The Evidence-Based Supplement Protocol

← Back to articles

Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction affecting roughly 10% of adults. No supplement cures it, and placebo response in IBS trials is famously high (often 30–40%), so honest grading matters. Two interventions have the best evidence — a low-FODMAP diet and enteric-coated peppermint oil — followed by specific probiotic strains and soluble fibre. The sections below are ordered by strength of evidence, and effects are modest even for the best-supported options.

Low-FODMAP Diet — Strongest Foundation (Not a Supplement)

The most evidence-based dietary intervention is a structured low-FODMAP diet (limiting fermentable oligo-, di-, and monosaccharides and polyols). A meta-analysis of six RCTs and sixteen non-randomized studies found significantly greater reductions in IBS Symptom Severity Scores and improved quality of life versus control diets (Marsh 2016), and the 2021 American College of Gastroenterology guideline recommends a limited trial of it for global symptoms (Lacy 2021). It is best run as a three-phase process — strict elimination for 4–6 weeks, then structured reintroduction, then long-term personalization to your own triggers — ideally with a dietitian, since prolonged blanket restriction can compromise nutrition and the gut microbiome.

Enteric-Coated Peppermint Oil — Moderate Evidence

Peppermint oil has the best supplement-grade evidence in IBS, acting as a smooth-muscle antispasmodic. A 2014 meta-analysis (9 trials, 726 patients) found it roughly doubled the likelihood of global symptom improvement (relative risk 2.23) and abdominal-pain improvement (RR 2.14) versus placebo (Khanna 2014). A 2019 Lancet network meta-analysis ranked peppermint oil first among traditional therapies for global IBS symptoms (RR 0.63 for failing to improve) (Black 2019). A 2022 update tempered this — still significant (RR 0.65, number-needed-to-treat about 4) but with more adverse events and very-low-quality evidence overall (Ingrosso 2022). Typical dose: 180–225 mg enteric-coated, two to three times daily before meals. Cautions: heartburn/reflux is the most common side effect; the enteric coating reduces it. See our peppermint oil piece.

Probiotics — Strain-Specific, Modest Evidence

As a class, probiotics modestly reduce IBS symptoms: a meta-analysis of 43 RCTs found a relative risk of 0.79 for remaining symptomatic, with benefit on global symptoms, pain, bloating, and flatulence — but the authors emphasized that which species and strains help most remains unclear (Ford 2014). The cleanest single-strain signal is Bifidobacterium infantis 35624: in a 362-patient multicenter RCT, the 1×10⁸ cfu dose beat placebo on abdominal pain and a composite symptom score by more than 20%, while higher and lower doses did not (Whorwell 2006) — a reminder that dose and strain are decisive. How to use: pick a single product with strain-level evidence, take it for about 4 weeks, and stop if there's no benefit. See our B. infantis 35624 piece and strain-level decision logic.

Soluble Fibre (Psyllium) — Limited-to-Moderate Evidence

Soluble fibre is the right kind of fibre for IBS. In a 275-patient primary-care RCT, psyllium (ispaghula) 10 g/day produced significantly more responders than placebo over the first two months (57% vs 35%; RR 1.60) and a larger reduction in symptom severity, whereas insoluble bran was no better than placebo and caused more dropouts from worsening symptoms (Bijkerk 2009). The 2021 ACG guideline supports soluble (not insoluble) fibre. Typical dose: start ~3–5 g/day and ramp slowly toward ~10 g to limit gas and bloating. Psyllium does not currently have a resolving SupplementScore entry, so it is left unlinked here. See our soluble-fibre piece.

What Doesn't Work / Overhyped

Avoid insoluble wheat bran and highly fermentable prebiotic fibres (inulin, FOS) — they tend to worsen bloating and pain in IBS (Bijkerk 2009). Berberine is sometimes promoted for IBS-D or SIBO overlap, but the controlled evidence is thin and we do not consider it established; if used, it should be clinician-directed and time-limited. Glutamine is not an established IBS therapy and shouldn't be a routine recommendation. Skip "leaky gut" protocols and digestive-enzyme megaformulas in the absence of a confirmed diagnosis such as pancreatic insufficiency. And do not substitute supplements for prescription therapy (for example rifaximin, linaclotide, or eluxadoline) in moderate-to-severe disease.

How to Run the Protocol

First confirm the diagnosis with a clinician and rule out red flags — fever, weight loss, rectal bleeding, anemia, or onset after age 50 warrant evaluation, not self-treatment. Begin with a structured low-FODMAP trial and identify your personal triggers. For symptom relief, a 4-week trial of enteric-coated peppermint oil is the most evidence-based supplement, and soluble fibre (psyllium, ramped slowly) helps stool consistency in both constipation- and diarrhea-predominant IBS. If you try a probiotic, choose one strain with trial evidence and judge it over about 4 weeks. Change one thing at a time so you can tell what actually works, and escalate to subtype-specific prescription therapy and gut-directed psychotherapy (which the ACG endorses) when symptoms remain disruptive.